Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cate Speake

Showing results (11-20 of 118) with videos related to

Pageof 12
Sort By:
Nature Communications|November 8, 2023
A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetesAlyssa Ylescupidez, Henry T Bahnson, Colin O'Rourke, et al.
Diabetes Care|April 24, 2025
Type 1 Diabetes TrialNet: Leading the Charge in Disease Prediction, Prevention, and Immunotherapeutic Mechanistic UnderstandingLaura M Jacobsen, Jamie L Felton, Brandon M Nathan, et al.
Plos One|December 14, 2023
Testing a new platform to screen disease-modifying therapy in type 1 diabetesSandra M Lord, Henry T Bahnson, Carla J Greenbaum, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2022
Risk Modeling to Reduce Monitoring of an Autoantibody-Positive Population to Prevent DKA at Type 1 Diabetes DiagnosisColin O'Rourke, Alyssa Ylescupidez, Henry T Bahnson, et al.
Cellular Immunology|November 16, 2018
Analysis of pancreatic beta cell specific CD4+ T cells reveals a predominance of proinsulin specific cellsGabriele Blahnik, Hannes Uchtenhagen, I-Ting Chow, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2024
Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 DiabetesStephan Pribitzer, Colin O'Rourke, Alyssa Ylescupidez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2022
Fewer LAG-3<sup>+</sup> T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 DiabetesBritta E Jones, Megan D Maerz, Henry T Bahnson, et al.
Journal of Clinical Medicine|April 30, 2021
Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19Alyssa Ylescupidez, Aaron Rips, Henry T Bahnson, et al.
Clinical Immunology (Orlando, Fla.)|June 25, 2017
Attenuated IL-2R signaling in CD4 memory T cells of T1D subjects is intrinsic and dependent on activation stateKatharine Schwedhelm, Jerill Thorpe, Sara A Murray, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2017
Antigen-Specific T Cell Analysis Reveals That Active Immune Responses to β Cell Antigens Are Focused on a Unique Set of EpitopesJunbao Yang, Xiaomin Wen, Hengyu Xu, et al.
Pageof 12

Showing results (11-20 of 118) with videos related to

Sort By:
Pageof 12
Nature Communications|November 8, 2023
A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetesAlyssa Ylescupidez, Henry T Bahnson, Colin O'Rourke, et al.
Diabetes Care|April 24, 2025
Type 1 Diabetes TrialNet: Leading the Charge in Disease Prediction, Prevention, and Immunotherapeutic Mechanistic UnderstandingLaura M Jacobsen, Jamie L Felton, Brandon M Nathan, et al.
Plos One|December 14, 2023
Testing a new platform to screen disease-modifying therapy in type 1 diabetesSandra M Lord, Henry T Bahnson, Carla J Greenbaum, et al.
The Journal of Clinical Endocrinology and Metabolism|October 13, 2022
Risk Modeling to Reduce Monitoring of an Autoantibody-Positive Population to Prevent DKA at Type 1 Diabetes DiagnosisColin O'Rourke, Alyssa Ylescupidez, Henry T Bahnson, et al.
Cellular Immunology|November 16, 2018
Analysis of pancreatic beta cell specific CD4+ T cells reveals a predominance of proinsulin specific cellsGabriele Blahnik, Hannes Uchtenhagen, I-Ting Chow, et al.
The Journal of Clinical Endocrinology and Metabolism|May 7, 2024
Beyond Stages: Predicting Individual Time Dependent Risk for Type 1 DiabetesStephan Pribitzer, Colin O'Rourke, Alyssa Ylescupidez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 13, 2022
Fewer LAG-3<sup>+</sup> T Cells in Relapsing-Remitting Multiple Sclerosis and Type 1 DiabetesBritta E Jones, Megan D Maerz, Henry T Bahnson, et al.
Journal of Clinical Medicine|April 30, 2021
Early Prognostic Indicators of Subsequent Hospitalization in Patients with Mild COVID-19Alyssa Ylescupidez, Aaron Rips, Henry T Bahnson, et al.
Clinical Immunology (Orlando, Fla.)|June 25, 2017
Attenuated IL-2R signaling in CD4 memory T cells of T1D subjects is intrinsic and dependent on activation stateKatharine Schwedhelm, Jerill Thorpe, Sara A Murray, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 28, 2017
Antigen-Specific T Cell Analysis Reveals That Active Immune Responses to β Cell Antigens Are Focused on a Unique Set of EpitopesJunbao Yang, Xiaomin Wen, Hengyu Xu, et al.
Pageof 12